ARTICLE | Clinical News
VTP-34072: Phase II data
July 13, 2015 7:00 AM UTC
Top-line data from a double-blind, German Phase II trial in overweight Type II diabetics showed that once-daily oral VTP-34072 as an add-on to metformin background therapy missed Boehringer’s “predefi...